Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch.

Gatault, Philippe

Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch. [electronic resource] - Human immunology Dec 2013 - 1616-8 p. digital

Publication Type: Case Reports; Journal Article

1879-1166

10.1016/j.humimm.2013.08.278 doi


Antibodies, Monoclonal, Murine-Derived--administration & dosage
B-Lymphocytes--drug effects
Complement System Proteins--immunology
Cytotoxicity, Immunologic--drug effects
Graft Rejection--immunology
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunologic Factors--administration & dosage
Kidney Transplantation--adverse effects
Male
Middle Aged
Rituximab